<DOC>
	<DOC>NCT01199315</DOC>
	<brief_summary>The purpose of this study is to assess safety, tolerability and pharmacokinetics of AZD1446 in young and elderly healthy Japanese volunteers.</brief_summary>
	<brief_title>A Study to Assess the Safety, Tolerability and Pharmacokinetics of Modified-Release Formulations of AZD1446 After Oral Single and Repeated Doses</brief_title>
	<detailed_description />
	<criteria>Healthy Japanese volunteers, aged ≥20 to ≤50 years for male young volunteers, ≥65 to ≤80 years for male or postmenopausal female elderly volunteers. BMI between 18 and 27 kg/m2 and weigh at least 50 kg and no more than 90 kg (for the elderly female, weigh at least 45 kg and no more than 90 kg). History of severe allergy/hypersensitivity reactions including drugallergy or drug hypersensitivity reactions, or ongoing allergy/hypersensitivity. History or present symptoms or signs of Quincke oedema, angiooedema, or urticaria pigmentosa, or history of repeated episodes of urticaria.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>AZD1446</keyword>
	<keyword>AD</keyword>
	<keyword>ADHD</keyword>
	<keyword>Japanese</keyword>
</DOC>